about
RNA interference screening identifies lenalidomide sensitizers in multiple myeloma, including RSK2.Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M(3)P).Cereblon binding molecules in multiple myeloma.Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple myeloma patients.Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes.Targeted sequencing using a 47 gene multiple myeloma mutation panel (M(3) P) in -17p high risk disease.Proteasome inhibitors block Ikaros degradation by lenalidomide in multiple myeloma.Evaluation and Treatment of Acute and Subacute Hearing Loss: A Review of Pharmacotherapy.CRISPR Genome-Wide Screening Identifies Dependence on the Proteasome Subunit PSMC6 for Bortezomib Sensitivity in Multiple Myeloma.Loss of FAM46C Promotes Cell Survival in Myeloma.Cutaneous Adverse Effects of Diabetes Mellitus Medications and Medical Devices: A ReviewSevere Myositis, Myocarditis, and Myasthenia Gravis with Elevated Anti-Striated Muscle Antibody following Single Dose of Ipilimumab-Nivolumab Therapy in a Patient with Metastatic Melanoma
P50
Q34974049-BCD9E2AD-DD11-4A63-B2A7-86E4F7F066BDQ36306807-BE9D29D1-382F-4C0F-A4F1-002AD9E61F9BQ38406398-836AF3CD-0A7E-4B65-BBED-58FC49D0E431Q38686915-FFC6AE37-78C0-4F09-A6C1-53CD3A421298Q39560208-E75F8551-D2E6-44C9-B495-9D26638FFF0DQ41766580-1D690302-300D-4BAF-9330-1E2A8EF053A9Q42399854-3CA5599E-9962-430B-BAD1-4484FF232162Q48201234-DD212A8F-1923-4331-B79A-59E71B009B01Q49660927-F3C581F5-2473-4811-8E68-2943EBB37E36Q50942246-9E9D52C0-0681-40A1-A4C0-A4B00DC84DFCQ58551987-E0259BCC-0CFA-4471-862C-49D3C40F1227Q92645868-EA2E933F-D8A9-43B1-A762-7C22706C96C9
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Patrick Jedlowski
@en
Patrick Jedlowski
@nl
type
label
Patrick Jedlowski
@en
Patrick Jedlowski
@nl
prefLabel
Patrick Jedlowski
@en
Patrick Jedlowski
@nl
P31
P496
0000-0001-8950-0965